Share on StockTwits

Omega Diagnostics Group Plc (LON:ODX)‘s stock had its “corporate” rating restated by FinnCap in a research note issued on Thursday, Analyst Ratings Network reports. They currently have a GBX 25 ($0.41) price objective on the stock. FinnCap’s target price would suggest a potential upside of 26.58% from the company’s current price.

Shares of Omega Diagnostics Group Plc (LON:ODX) traded up 17.91% during mid-day trading on Thursday, hitting GBX 19.75. The stock had a trading volume of 2,107,530 shares. Omega Diagnostics Group Plc has a 52 week low of GBX 12.11 and a 52 week high of GBX 19.562. The stock has a 50-day moving average of GBX 17.69 and a 200-day moving average of GBX 15.93.

Omega Diagnostics Group PLC is engaged in manufacture, development and distribution of medical diagnostics products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.